Evolution Wealth Advisors LLC trimmed its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 11.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,115 shares of the company’s stock after selling 1,385 shares during the quarter. Evolution Wealth Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $176,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of BMEZ. Dakota Wealth Management increased its stake in shares of BlackRock Health Sciences Term Trust by 5.3% in the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after buying an additional 915 shares in the last quarter. Oppenheimer & Co. Inc. increased its position in BlackRock Health Sciences Term Trust by 0.6% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after acquiring an additional 1,153 shares in the last quarter. Brown Lisle Cummings Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 6.2% in the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after acquiring an additional 2,128 shares during the last quarter. Comerica Bank lifted its position in shares of BlackRock Health Sciences Term Trust by 31.1% during the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after purchasing an additional 3,671 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 11.2% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 65,088 shares of the company’s stock valued at $1,000,000 after purchasing an additional 6,565 shares during the last quarter.
Insider Transactions at BlackRock Health Sciences Term Trust
In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. bought 15,455 shares of BlackRock Health Sciences Term Trust stock in a transaction dated Thursday, September 19th. The stock was bought at an average cost of 16.14 per share, for a total transaction of 249,443.70. Following the purchase, the insider now owns 20,601,568 shares of the company’s stock, valued at 332,509,307.52. The trade was a 0.08 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have bought 99,630 shares of company stock worth $1,585,113 in the last ninety days.
BlackRock Health Sciences Term Trust Stock Performance
BlackRock Health Sciences Term Trust Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.1769 per share. The ex-dividend date is Friday, November 15th. This represents a $2.12 annualized dividend and a dividend yield of 13.91%.
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What is the NASDAQ Stock Exchange?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Top Stocks Investing in 5G Technology
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.